Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
• EFSL is the Edelweiss group's financial services arm.
• It suffered a minor setback for FY22 on account of the Pandemic.
• It has sound financial status and is poised for steady growth with a variety of services.
• This debt offer is rated CRISIL AA- /(Negative) and ACUITE AA-/ (Negative).
• Investors looking for a steady income may park funds for the medium to long term.
ABOUT COMPANY:
Edelweiss Financial Services Ltd. (EFSL) - erstwhile known as Edelweiss Capital Ltd. commenced its business as an investment banking firm, it diversified through its subsidiaries to include credit including retail and corporate credit, asset management including mutual fund and alternative asset management business, asset reconstruction, insurance both life and general insurance business, and wealth management business.
It has a Pan-India and international network with 230 domestic offices, and 3 international offices (a total of 233 offices) and employs 5,981 employees, the group comprises 28 subsidiaries as of March 31, 2023.
ISSUE DETAILS:
The company is coming out with its July 23 Tranche-III Secured Redeemable NCDs having a face value of Rs. 1000 each for an amount of Rs. 150 cr. with a green shoe option of retaining oversubscription up to Rs. 150 cr., thus making an overall issue size of Rs. 300 cr. The issue opens for subscription on July 04, 2023, and will close on or before July 17, 2023. It has a shelf limit of Rs. 1000 cr.
Equirus Capital Pvt. Ltd. is the sole lead manager for this issue and KFin Technologies Ltd. is the registrar of the issue. Beacon Trusteeship Ltd. is the Debenture Trustee.
The company is spending Rs. 6.80 cr. for this debt offer and from the net proceeds, it will utilize at least 75% for the purpose of repayment/prepayment of existing borrowings with interest, and a maximum of up to 25% for general corporate purposes.
A minimum application is to be made for 10 NCDs (i.e. Rs. 10000) and in multiple of 1NCD (i.e. Rs. 1000) thereon, thereafter. Post allotment, NCDs will be listed on BSE.
This debt offering carries coupon rates ranging between 8.95% to 10.45% based on the series opted by the investors. It has tenors of 24 months, 36 months, 60 months and 120 months. It is offering an additional incentive of 0.20% p.a. to all eligible bondholders of the group companies as of the specified record date.
The company has allocated 10% for Institutional investors, 10% for Non-institutional investors, 40% for HNIs and 40% for Retail investors.
ISSUE RATINGS:
This issue is rated CRISIL AA-/(Negative) by CRISIL Ratings Ltd., and ACUITE AA-/(Negative) by Acuite Ratings and Research Ltd.
The ratings given by the Credit Rating Agencies are valid as of the date of this Tranche III Prospectus and shall remain valid until the ratings are revised or withdrawn. The rating is not a recommendation to buy, sell or hold securities and investors should take their own decision. The rating may be subject to revision or withdrawal at any time by the assigning rating agency and each rating should be evaluated independently of any other rating. The rating agency has a right to suspend or withdraw the rating at any time on the basis of factors such as new information.
FINANCIAL PERFORMANCE:
On the financial performance front, for the last three fiscals, EFSL has posted a total income of Rs. 10954.94 cr. / Rs. 253.92 cr. (FY21), Rs. 7212.59 cr. / Rs. 212.07 cr. (FY22), and Rs. 8632.59 cr. / Rs. 405.56 cr. (FY23). It suffered a setback for FY22 in line with the general trends following the Pandemic.
As of March 31, 2023, its paid-up equity capital of Rs. 89.84 cr. is supported by a free reserve of Rs. 6654.27 cr. Its Net NPAs stood at 1.36% as of the said date. Its debt/equity ratio of 0.36 as of March 31, 2023, will increase to 0.40 post this issue.
Review By Dilip Davda on July 3, 2023
DISCLAIMER: No financial information whatsoever published anywhere here should be construed as an offer to buy or sell securities, or as advice to do so in any way whatsoever. All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions. Readers must consult a qualified financial advisor before making any actual investment decisions, based on the information published here. My reviews do not cover GMP market and operators game plans. Any reader taking decisions based on any information published here does so entirely at their own risk. Investors should bear in mind that any investment in stock markets is subject to unpredictable market-related risks. The above information is based on RHP and other documents available as of date coupled with market perception. The author has no plans to invest in this offer.
About Dilip Davda
Dilip Davda is veteran journalist associated with stock market since 1978. He is contributing to print and electronic media on stock markets/insurance/finance since 1985.
Dilip Davda is a leading reviewer of public issues and NCDs in the primary stock market in India. The knowledge he gained over 3 decades while working in the stock market and a strong relationship with popular lead managers makes his reviews unique. His detail fundamental and financial analysis of companies coming up with IPO helps investors in the primary stock market. Dilip Davda has a special interest in analyzing the SME companies and writing reviews about their public issues. His reviews are regularly published online and in news papers.
(Dilip Davda -SEBI registered Research Analyst-Mumbai,
Registration no. INH000003127 (Perpetual)
Email id: dilip_davda@rediffmail.com ).
The Edelweiss Financial NCD Tranche III July 2023 Analysis helps you to understand about the company, offer detail, valuation, capital structure and financial performance. Our SEBI registered NCD Analysts tells you if Edelweiss Financial NCD Tranche III July 2023 worth investing. The Edelweiss Financial NCD Tranche III July 2023 Note sets the NCD expectations in systematic way which tells you if Edelweiss Financial NCD Tranche III July 2023 good to buy (good or bad / yes or no). The NCD Forecast tells you weather to invest in Edelweiss Financial NCD Tranche III July 2023 by providing NCD recommendations i.e. subscribe, avoid and neutral.
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
